Posts in category

Mortgage Blog


After Elizabeth Hale moved to Arizona, she launched eeCPA in 2004, a Scottsdale-based accounting and tax firm whose clients include business owners, family offices and commercial real estate developers. And that's not the only business she has started.

As executive director of Civic Progress, Tom Irwin said that he and Michael Neidorff, the late chairman and CEO of Clayton-based Centene Corp., shared the same belief about the role big businesses play in the places they call home.

“If you are located in a community and you have a large number of employees, de facto you have an obligation to that community,” said Irwin, who retired in 2018 as head of the now-defunct organization comprised of CEOs and other leading executives in the St. Louis…

The government alleges that UMR Inc., a Wisconsin-based administrator owned by UnitedHealth, improperly denied payments for emergency room visits and urine drug screens.

“Former Mayor Coleman has helped to make this dream a reality since the very beginning, and there is no better person to lead our board of directors,” Adelphi Chairman and CEO Jordan Miller said.

Fifth Third Bank is opening eight new branches in the Southeast, part of a move to expand there.

Service Corp. International reported revenues and earnings per share that were higher than analysts' expectations for the second quarter.

Pfizer has lowered its full-year revenue guidance in part due to its facility in Eastern North Carolina being temporarily shut down after it was damaged by a tornado last month.

Mayor Rick Blangiardi signed a bill into law last week that requires bars and restaurants with liquor licenses in Honolulu carry naloxone spray, which is used to prevent opioid overdoses.

“Our KeikiCo Contest never fails to amaze us with the incredible talent displayed by Hawaii’s young leaders,” Ann Teranishi, president and CEO at ASB, said in a statement.

Peter Hecht, the co-founder and CEO of embattled biotech Cyclerion Therapeutics Inc. (Nasdaq: CYCN), is heading up a new startup that's effectively a life raft for Cyclerion's research. Elsewhere in the Petri Dish: a $1 billion deal for Pfizer gene therapies, a succession plan for a founder-led biotech organization, and a new Longwood Fund spinout with assets from GSK.